2023
DOI: 10.1021/acs.jmedchem.2c01905
|View full text |Cite
|
Sign up to set email alerts
|

New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate Staphylococcus aureus

Abstract: A new series of dual low nanomolar benzothiazole inhibitors of bacterial DNA gyrase and topoisomerase IV were developed. The resulting compounds show excellent broad-spectrum antibacterial activities against Gram-positive Enterococcus faecalis , Enterococcus faecium and multidrug resistant (MDR) Staphylococcus aureus strains [best compound minimal inhibitory concentrations (MICs): range, <0.03125–0.25 μg/mL] and against the Gram-negatives … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

2
3

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 45 publications
0
5
0
Order By: Relevance
“…The design of new DNA gyrase inhibitor-siderophore mimic conjugates started from our potent GyrB/ParE inhibitors A and B (Table 1) that exhibited antibacterial activity against G+ and G− ESKAPE pathogens, limited potential for resistance development and efficacy in in vivo infection models. 13,14,36,37 The cocrystal structures of benzothiazole GyrB inhibitors in complex with S. aureus GyrB showed that the pyrrolamide moiety forms two hydrogen bonds with Asp81 (S. aureus GyrB numbering) and crystal water molecule as well as an extensive network of hydrophobic contacts. The benzothiazole core is engaged in the formation of cation-p interaction with Arg84 and substitution at position 4 allows for improving the physico-chemical properties and binding affinity by formation of additional interactions in the lipophilic oor of the binding site.…”
Section: Design and Synthesismentioning
confidence: 99%
See 2 more Smart Citations
“…The design of new DNA gyrase inhibitor-siderophore mimic conjugates started from our potent GyrB/ParE inhibitors A and B (Table 1) that exhibited antibacterial activity against G+ and G− ESKAPE pathogens, limited potential for resistance development and efficacy in in vivo infection models. 13,14,36,37 The cocrystal structures of benzothiazole GyrB inhibitors in complex with S. aureus GyrB showed that the pyrrolamide moiety forms two hydrogen bonds with Asp81 (S. aureus GyrB numbering) and crystal water molecule as well as an extensive network of hydrophobic contacts. The benzothiazole core is engaged in the formation of cation-p interaction with Arg84 and substitution at position 4 allows for improving the physico-chemical properties and binding affinity by formation of additional interactions in the lipophilic oor of the binding site.…”
Section: Design and Synthesismentioning
confidence: 99%
“…1). 13,14,36,37 In the design of conjugates with siderophore mimics, we considered two different approaches. In the rst design strategy, the 6-carboxylic acid was reacted with the 2-(aminomethyl)-5-hydroxy-4H-pyran-4-one or 2-(aminomethyl)-5hydroxypyridin-4(1H)-one to form the amide derivatives 10 and 12.…”
Section: Design and Synthesismentioning
confidence: 99%
See 1 more Smart Citation
“…During our ongoing research on DNA gyrase and Topo IV inhibitors, we discovered ATP-competitive benzothiazole scaffold-based inhibitors that display potent antibacterial activity against ESKAPE pathogens. As a part of our hit-to-lead development stage, we expanded the chemical space of the benzothiazole-based series to the synthetically challenging C5 position of the benzothiazole ring. In this paper, we present new inhibitors with a broad spectrum of activity against Gram-positive and Gram-negative bacteria and investigate their possible binding modes by a combination of docking calculations, molecular dynamics (MD) simulations, and MD-derived structure-based pharmacophore modeling.…”
Section: Introductionmentioning
confidence: 99%
“…In this article, morpholine derivatives, known for their robust antibacterial and antifungal properties, have garnered attention (Durcik et al 2023). These derivatives show activity against enzymes essential for DNA synthesis, along with in uencing cellular stress response, rendering them valuable for combating a wide spectrum of bacteria and fungi (Ohui et al 2019).…”
Section: Introductionmentioning
confidence: 99%